The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Critical Analysis of the Commercial Potential of Plants for the Production of Recombinant Proteins
Open accessAbstract
Over the last three decades, the expression of recombinant proteins in plants and plant cells has been promoted as an alternative cost-effective production platform. However, the market is still dominated by prokaryotic and mammalian expression systems, the former offering high production capacity at a low cost, and the latter favored for the production of complex biopharmaceutical products. Although plant systems are now gaining widespread acceptance as a platform for the larger-scale production of recombinant proteins, there is still resistance to commercial uptake. This partly reflects the relatively low yields achieved in plants, as well as inconsistent product quality and difficulties with larger-scale downstream processing. Furthermore, there are only a few cases in which plants have demonstrated economic advantages compared to established and approved commercial processes, so industry is reluctant to switch to plant-based production. Nevertheless, some plant-derived proteins for research or cosmetic/pharmaceutical applications have reached the market, showing that plants can excel as a competitive production platform in some niche areas. Here, we discuss the strengths of plant expression systems for specific applications, but mainly address the bottlenecks that must be overcome before plants can compete with conventional systems, enabling the future commercial utilization of plants for the production of valuable proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Production of antibodies in transgenic plants
Hiatt, A., Caffferkey, R., & Bowdish, K. (1989) · Nature · doi:10.1038/342076a0 · Cited by 1,059
Biopharmaceutical benchmarks 2018
Walsh, G. (2018) · Nature Biotechnology · doi:10.1038/nbt.4305 · Cited by 978
Microbial enzymes: industrial progress in 21st century
Singh, R., Kumar, M., Mittal, A., & Mehta, P. K. (2016) · 3 Biotech · doi:10.1007/s13205-016-0485-8 · Cited by 904
Molecular farming in plants: host systems and expression technology
Twyman, R. M., Stoger, E., Schillberg, S., Christou, P., & Fischer, R. (2003) · Trends in Biotechnology · doi:10.1016/j.tibtech.2003.10.002 · Cited by 693
Self-citationGeneration and Assembly of Secretory Antibodies in Plants
Ma, J. K.-C., Hiatt, A., Hein, M., Vine, N. D., Wang, F., Stabila, P., van Dolleweerd, C., Mostov, K., & Lehner, T. (1995) · Science · doi:10.1126/science.7732380 · Cited by 612
Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals
Cosa, B. D., Moar, W., Lee, S.-B., Miller, M., & Daniell, H. (2001) · Nature Biotechnology · doi:10.1038/83559 · Cited by 582
Marillonnet, S., Thoeringer, C., Kandzia, R., Klimyuk, V., & Gleba, Y. (2005) · Nature Biotechnology · doi:10.1038/nbt1094 · Cited by 528
Cell factories for insulin production
Baeshen, N. A., Baeshen, M. N., Sheikh, A., Bora, R. S., Ahmed, M. M. M., Ramadan, H. A. I., Saini, K. S., & Redwan, E. M. (2014) · Microbial Cell Factories · doi:10.1186/s12934-014-0141-0 · Cited by 359
Recombinant pharmaceuticals from microbial cells: a 2015 update
Sanchez-Garcia, L., Martín, L., Mangues, R., Ferrer-Miralles, N., Vázquez, E., & Villaverde, A. (2016) · Microbial Cell Factories · doi:10.1186/s12934-016-0437-3 · Cited by 339
Very Large Scale Monoclonal Antibody Purification: The Case for Conventional Unit Operations
Kelley, B. (2007) · Biotechnology Progress · doi:10.1021/bp070117s · Cited by 337
Cited by
Tripathi, N. K., & Shrivastava, A. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00420 · Cited by 575
Sustaining Protein Nutrition Through Plant-Based Foods
Langyan, S., Yadava, P., Khan, F. N., Dar, Z. A., Singh, R., & Kumar, A. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.772573 · Cited by 361
Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production
Shanmugaraj, B., I. Bulaon, C. J., & Phoolcharoen, W. (2020) · Plants · doi:10.3390/plants9070842 · Cited by 257
Development of spirulina for the manufacture and oral delivery of protein therapeutics
Jester, B. W., Zhao, H., Gewe, M., Adame, T., Perruzza, L., Bolick, D. T., Agosti, J., Khuong, N., Kuestner, R., Gamble, C., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01249-7 · Cited by 130
Ruiz-Molina, N., Parsons, J., Schroeder, S., Posten, C., Reski, R., & Decker, E. L. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.837965 · Cited by 14
Metadata
- Authors
- Schillberg, S., Raven, N., Spiegel, H., Rasche, S., & Buntru, M.
- Venue
- Frontiers in Plant Science
- Publisher
- Frontiers Media SA
- Published
- 2019-06-11
- Volume
- 10
- Pages
- 720-720
- ISSN
- 1664-462X (ISSN-L)
- OpenAlex
- W2945686955
- Cited by
- 261
- References
- 33
- FWCI
- 17.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.